Estelle Clermont-Taranchon
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.
Journal: Nature communications
Published: March 02, 2024
Usefulness of an RNA extraction-free test for the multiplexed detection of ALK, ROS1, and RET Gene Fusions in Real Life FFPE Specimens of Non-Small Cell Lung Cancers.
Journal: Expert review of molecular diagnostics
Published: October 31, 2023
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Clinical and molecular analysis of lung cancers associated with fibrosing interstitial lung disease.
Journal: Respiratory medicine and research
Published: March 10, 2022
Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1.
Journal: Biomarker research
Published: July 17, 2019
Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
Journal: The Journal of molecular diagnostics : JMD
Published: September 06, 2018
Cytoplasmic p27Kip1 promotes tumorigenesis via suppression of RhoB activity.
Journal: The Journal of pathology
Published: April 10, 2018
CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignancies.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 06, 2016
Interest of crizotinib in a lung cancer patient with de novo amplification of MET
Journal: Revue des maladies respiratoires
Published: November 20, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026